The role of Nuclear Factor-kappa B signaling in human cervical cancer
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
The NF- B Family of Transcription Factors and Its Regulation
Oeckinghaus, A., & Ghosh, S. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000034 · Cited by 2,842
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Papillomaviruses in the causation of human cancers - a brief historical account
zur Hausen, H. (2009) · Virology · doi:10.1016/j.virol.2008.11.046 · Cited by 1,532
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
NF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Tomasetti, C., Li, L., & Vogelstein, B. (2017) · Science · doi:10.1126/science.aaf9011 · Cited by 1,113
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Landscape of genomic alterations in cervical carcinomas
Ojesina, A. I., Lichtenstein, L., Freeman, S. S., Pedamallu, C. S., Imaz-Rosshandler, I., Pugh, T. J., Cherniack, A. D., Ambrogio, L., Cibulskis, K., Bertelsen, B., et al. (2014) · Nature · doi:10.1038/nature12881 · Cited by 867
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
Role of NF-κB in p53-mediated programmed cell death
Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 740
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 649
Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809784106 · Cited by 627
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Yang, J., Liao, X., Agarwal, M. K., Barnes, L., Auron, P. E., & Stark, G. R. (2007) · Genes & Development · doi:10.1101/gad.1553707 · Cited by 611
The cellular response to p53: the decision between life and death
Sionov, R. V., & Haupt, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203130 · Cited by 601
Kraus, W. L., & Lis, J. T. (2003) · Cell · doi:10.1016/s0092-8674(03)00433-1 · Cited by 546
Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli
Wu, Z.-H., Shi, Y., Tibbetts, R. S., & Miyamoto, S. (2006) · Science · doi:10.1126/science.1121513 · Cited by 515
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Caamaño, J., & Hunter, C. A. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.3.414-429.2002 · Cited by 510
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489
Disis, M. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2146 · Cited by 489
Matsumoto, Y., Marusawa, H., Kinoshita, K., Endo, Y., Kou, T., Morisawa, T., Azuma, T., Okazaki, I.-M., Honjo, T., & Chiba, T. (2007) · Nature Medicine · doi:10.1038/nm1566 · Cited by 479
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2011) · Oncogene · doi:10.1038/onc.2010.566 · Cited by 473
Role of Stat3 in Regulating p53 Expression and Function
Niu, G., Wright, K. L., Ma, Y., Wright, G. M., Huang, M., Irby, R., Briggs, J., Karras, J., Cress, W. D., Pardoll, D., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7432-7440.2005 · Cited by 392
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387
Stat3 regulates genes common to both wound healing and cancer
Dauer, D. J., Ferraro, B., Song, L., Yu, B., Mora, L., Buettner, R., Enkemann, S., Jove, R., & Haura, E. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208469 · Cited by 380
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
Patel, D., Huang, S., Baglia, L. A., & McCance, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5061 · Cited by 374
Cyclooxygenase-2 is overexpressed in human cervical cancer.
Kulkarni, S., Rader, J. S., Zhang, F., Liapis, H., Koki, A. T., Masferrer, J. L., Subbaramaiah, K., & Dannenberg, A. J. (2001) · PubMed · Cited by 367
Henderson, S., Chakravarthy, A., Su, X., Boshoff, C., & Fenton, T. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.012 · Cited by 345
Recruitment of a ROC1–CUL1 Ubiquitin Ligase by Skp1 and HOS to Catalyze the Ubiquitination of IκBα
Tan, P., Fuchs, S. Y., Chen, A., Wu, K., Gomez, C., Ronai, Z., & Pan, Z.-Q. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80481-5 · Cited by 345
IκBα Deficiency Results in a Sustained NF-κB Response and Severe Widespread Dermatitis in Mice
Klement, J. F., Rice, N. R., Car, B. D., Abbondanzo, S. J., Powers, G. D., Bhatt, H., Chen, C.-H., Rosen, C. A., & Stewart, C. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2341 · Cited by 340
Bonizzi, G., Bebien, M., Otero, D. C., Johnson‐Vroom, K. E., Cao, Y., Vu, D., Jegga, A. G., Aronow, B. J., Ghosh, G., Rickert, R. C., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600391 · Cited by 338
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
La Rosa, F. A., Pierce, J. W., & Sonenshein, G. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1039 · Cited by 283
Regulation of an essential innate immune response by the p50 subunit of NF-kappaB.
Bohuslav, J., Kravchenko, V. V., Parry, G. C., Erlich, J. H., Gerondakis, S., Mackman, N., & Ulevitch, R. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3877 · Cited by 279
NF-κB: tumor promoter or suppressor?
Perkins, N. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.004 · Cited by 261
Interactions of NF-κB with chromatin: the art of being at the right place at the right time
Natoli, G., Saccani, S., Bosisio, D., & Marazzi, I. (2005) · Nature Immunology · doi:10.1038/ni1196 · Cited by 250
Criswell, T., Leskov, K., Miyamoto, S., Luo, G., & Boothman, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206680 · Cited by 248
Rocha, S., Martin, A. M., Meek, D. W., & Perkins, N. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4713-4727.2003 · Cited by 239
NF-κB-mediated adaptive resistance to ionizing radiation
Mokim Ahmed, K., & Li, J. J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.022 · Cited by 226
The role of human papillomaviruses in carcinogenesis
Ghittoni, R. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.526 · Cited by 198
Achieving transcriptional specificity with nf-κb
Perkins, N. D. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00088-5 · Cited by 183
RelB Forms Transcriptionally Inactive Complexes with RelA/p65
Marienfeld, R. B., May, M. J., Berberich, I., Serfling, E., Ghosh, S., & Neumann, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301945200 · Cited by 174
Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences
Diamond, G., Beckloff, N., & Ryan, L. K. (2008) · Journal of Dental Research · doi:10.1177/154405910808701011 · Cited by 168
CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response
Vij, N., Mazur, S., & Zeitlin, P. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004664 · Cited by 166
Nair, S. A., Manickam, V., Maliekal, T. T., Nair, B., & Karunagaran, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206043 · Cited by 159
Kim, S. H., Juhnn, Y. S., Kang, S. B., Park, S. W., Sung, M. W., Bang, Y., & Song, Y. S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5561-x · Cited by 158
James, M. A., Lee, J. H., & Klingelhutz, A. J. (2006) · Journal of Virology · doi:10.1128/jvi.01942-05 · Cited by 155
Wong, D., Teixeira, A., Oikonomopoulos, S., Humburg, P., Lone, I. N., Saliba, D., Siggers, T., Bulyk, M., Angelov, D., Dimitrov, S., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-7-r70 · Cited by 152
Georgopoulos, N. T., Proffitt, J. L., & Blair, G. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203860 · Cited by 148
Papillomavirus DNA replication — From initiation to genomic instability
Kadaja, M., Silla, T., Ustav, E., & Ustav, M. (2009) · Virology · doi:10.1016/j.virol.2008.11.032 · Cited by 145
The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers
Leonard, B. C., McCann, J. L., Starrett, G. J., Kosyakovsky, L. B., Luengas, E. M., Molan, A. M., Burns, M. B., McDougle, R. M., Parker, P. J., Brown, W. L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2171-t · Cited by 145
Xie, T., Xia, Z., Zhang, N., Gong, W., & Huang, S. (2010) · PubMed · Cited by 138
Subbaramaiah, K., & Dannenberg, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4273 · Cited by 129
Spitkovsky, D., Hehner, S. P., Hofmann, T. G., Möller, A., & Schmitz, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201884200 · Cited by 124
AID/APOBEC deaminases and cancer
Rebhandl, S., Huemer, M., Greil, R., & Geisberger, R. (2015) · Oncoscience · doi:10.18632/oncoscience.155 · Cited by 121
Crusius, K., Auvinen, E., Steuer, B., Gaissert, H., & Alonso, A. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4024 · Cited by 118
The interaction between ER and NFκB in resistance to endocrine therapy
Sas, L., Lardon, F., Vermeulen, P. B., Hauspy, J., van Dam, P. A., Pauwels, P., Dirix, L. Y., & Laere, S. V. (2012) · Breast Cancer Research · doi:10.1186/bcr3196 · Cited by 113
Involvement of NF- B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein
Kim, S.-H., Oh, J.-M., No, J.-H., Bang, Y.-J., Juhnn, Y.-S., & Song, Y.-S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp066 · Cited by 112
Vandermark, E. R., Deluca, K. A., Gardner, C. R., Marker, D. F., Schreiner, C. N., Strickland, D. A., Wilton, K. M., Mondal, S., & Woodworth, C. D. (2012) · Virology · doi:10.1016/j.virol.2011.12.023 · Cited by 106
p53 and NF-κB Crosstalk: IKKα Tips the Balance
Tergaonkar, V., & Perkins, N. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.006 · Cited by 97
Branca, M., Ciotti, M., Santini, D., Bonito, L. D., Benedetto, A., Giorgi, C., Paba, P., Favalli, C., Costa, S., Agarossi, A., et al. (2004) · American Journal of Clinical Pathology · doi:10.1309/vqxft880jxc7qd2w · Cited by 75
Reward versus Risk: DNA Cytidine Deaminases Triggering Immunity and Disease
Pham, P., Bransteitter, R., & Goodman, M. F. (2005) · Biochemistry · doi:10.1021/bi047481+ · Cited by 73
Expression of Wild-Type CFTR Suppresses NF-κB-Driven Inflammatory Signalling
Hunter, M. J., Treharne, K. J., Winter, A. K., Cassidy, D. M., Land, S. C., & Mehta, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011598 · Cited by 69
Kim, M., Seo, S., Song, Y. S., Kang, D., Park, I.-A., Kang, S., & Lee, H. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00224-5 · Cited by 66
Post-translational modification of RelA(p65) NF-κB
Campbell, K. J., & Perkins, N. D. (2004) · Biochemical Society Transactions · doi:10.1042/bst0321087 · Cited by 62
Global Effects of Human Papillomavirus Type 18 E6/E7 in an Organotypic Keratinocyte Culture System
Garner-Hamrick, P. A., Fostel, J. M., Chien, W.-M., Banerjee, N. S., Chow, L. T., Broker, T. R., & Fisher, C. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9041-9050.2004 · Cited by 62
The NFκB Signaling Pathway in Papillomavirus-induced Lesions: Friend or Foe?
da Costa, R. M. G., Bastos, M. M. S. M., Medeiros, R., & Oliveira, P. A. (2016) · PubMed · Cited by 61
Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells
Maruyama, W., Shirakawa, K., Matsui, H., Matsumoto, T., Yamazaki, H., Sarca, A. D., Kazuma, Y., Kobayashi, M., Shindo, K., & Takaori‐Kondo, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.148 · Cited by 58
Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
Xiang, L., Li, J., Jiang, W., Shen, X., Yang, W., Wu, X., & Yang, H. (2014) · Oncotarget · doi:10.18632/oncotarget.3212 · Cited by 55
Dirix, L. Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1562 · Cited by 54
Ningegowda, R., Shivananju, N. S., Rajendran, P., Basappa, B., Rangappa, K. S., Chinnathambi, A., Li, F., Achar, R. R., Shanmugam, M. K., Bist, P., et al. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1312-8 · Cited by 54
Bonavida, B. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014011929 · Cited by 51
Xue, P., Wu, Z., Yu, L., Li, J., Xu, W., Chan, H. C., Zhang, Y., & Hu, L. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.02.015 · Cited by 49
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment
van Dam, P. A., van Dam, P., Rolfo, C. D., Giallombardo, M., Berckelaer, C. V., Trinh, X. B., Altıntaş, S., Huizing, M. T., Papadimitriou, K., Tjalma, W. A. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6667 · Cited by 48
Self-citationA Functional NF-κB Binding Site in the Human Papillomavirus Type 16 Long Control Region
Fontaine, V., van der Meijden, E., de Graaf, J., ter Schegget, J., & Struyk, L. (2000) · Virology · doi:10.1006/viro.2000.0363 · Cited by 46
Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection
Halemano, K., Guo, K., Heilman, K. J., Barrett, B. S., Smith, D. S., Hasenkrug, K. J., & Santiago, M. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403361111 · Cited by 42
Deshpande, R., Mansara, P., & Kaul-Ghanekar, R. (2015) · Tumor Biology · doi:10.1007/s13277-015-4170-z · Cited by 41
Lee, S., Cho, Y. S., Shim, C., Kim, J., Choi, J., Oh, S., Kim, J., Zhang, W., & Lee, J.-H. (2001) · International Journal of Cancer · doi:10.1002/ijc.1494 · Cited by 36
Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa
Chauhan, S. C., Jaggi, M., Bell, M. C., Verma, M., & Kumar, D. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_22 · Cited by 29
Nakahara, T., Tanaka, K., Ohno, S., Egawa, N., Yugawa, T., & Kiyono, T. (2015) · Journal of Virology · doi:10.1128/jvi.00389-15 · Cited by 29
Coward, W. R., Sagara, H., Wilson, S. J., Holgate, S. T., & Church, M. K. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02003.x · Cited by 28
Prabhavathy, D., Chandrasekaran, K. S., & Karunagaran, D. (2015) · Bioscience Reports · doi:10.1042/bsr20140160 · Cited by 27
Branca, M., Giorgi, C., Ciotti, M., Santini, D., Bonito, L. D., Costa, S. P. S., Benedetto, A., Bonifacio, D., Bonito, P. D., Paba, P., et al. (2006) · Diagnostic Cytopathology · doi:10.1002/dc.20514 · Cited by 27
Ishikawa, H., Ohno, T., Kato, S., Wakatsuki, M., Iwakawa, M., Ohta, T., Imai, T., Mitsuhashi, N., Noda, S., Nakano, T., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.007 · Cited by 24
Pallavi, S., Anoop, K., Showket, H., Alo, N., & Bharadwaj, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-3312-7 · Cited by 20
Ethiraj, P., Veerappan, K., Samuel, S., & Sundaresan, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.058 · Cited by 20
Partial loss of Smad signaling during in vitroprogression of HPV16-immortalized human keratinocytes
Altomare, D., Velidandla, R., Pirisi, L. A., & Creek, K. E. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-424 · Cited by 18
Cited by
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Cornel, A. M., Mimpen, I. L., & Nierkens, S. (2020) · Cancers · doi:10.3390/cancers12071760 · Cited by 464
The potential and controversy of targeting STAT family members in cancer
Verhoeven, Y., Tilborghs, S., Jacobs, J., De Waele, J., Quatannens, D., Deben, C., Prenen, H., Pauwels, P., Trinh, X. B., Wouters, A., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.002 · Cited by 409
Self-citationRole of cytokines and inflammation in heart function during health and disease
Bartekova, M., Radosinska, J., Jelemensky, M., & Dhalla, N. S. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9716-x · Cited by 293
Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Baba, A. B., Rah, B., Bhat, G. R., Mushtaq, I., Parveen, S., Hassan, R., Hameed Zargar, M., & Afroze, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.791272 · Cited by 224
Metadata
- Authors
- Tilborghs, S., Corthouts, J., Verhoeven, Y., Arias, D., Rolfo, C., Trinh, X. B., & van Dam, P. A.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 120
- Pages
- 141-150
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2767959705
- Cited by
- 269
- References
- 105
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.